Get started
Author

Yusuf Ziya Deniz

Observed names: Y. Deniz, YUSUF ZİYA DENİZ
ORCID: 0000-0002-7725-2359
Observed ORCID: 0000-0002-7725-2359
OpenAlex ID: A5066372118
The Role of the Low-Density Lipoprotein/High-Density Lipoprotein Cholesterol Ratio as an Atherogenic Risk Factor in Young Adults with Ischemic Stroke: A Case—Control Study
2023 · Sibel Ciplak, Ahmet Adiguzel, et al. · Brain Sciences · 12
PDF
Delayed diagnosis of carnitine palmitoyltransferase II deficiency in a 63-year-old man with recurrent rhabdomyolysis: a case report
2026 · Mehmet Fatih Uzanulu, Hacı Mehmet Çitil, et al. · Journal of Medical Case Reports
Rémission clinique avec le dupilumab chez les enfants atteints d’asthme de type 2 non contrôlé, modéré à sévère
2025 · L.B. Bacharier, P. Cros, et al. · Perfectionnement en Pédiatrie
DYSESTHESIA
2025 · YUSUF ZİYA DENİZ · Turkiye Klinikleri eBooks
SYNESTHESIA
2025 · YUSUF ZİYA DENİZ · Turkiye Klinikleri eBooks
A rare food poisoning: clostridium botulinum
2023 · Yusuf Ziya Deniz, Necip Nas · Intercontinental Journal of Internal Medicine
PDF
Long-term dupilumab reduces exacerbations and improves lung function in type 2 patients with/without allergic asthma
2023 · L. Sher, J. Corren, et al. · Revue française d'allergologie
Frequency of Covid-19 Infection and The Disease Profile in Patients Followed with Multiple Sclerosis
2023 · Yusuf Ziya Deniz, Mehmet Tecellioğlu, et al. · Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
Long-term Dupilumab Reduces Exacerbations and Improves Lung Function in Type 2 Patients With/without Allergic
2022 · L. Sher, J. Corren, et al. · Annals of Allergy Asthma & Immunology
Works count: 9
Citation count: 12
H-index: 1
I10-index: 1
Year
Topic
Type